Forty Seven Inc (FTSV)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
N/A
Employees:
57
1490 O'BRIEN DRIVE, SUITE A, MENLO PARK, CA 94025
(650) 352-4150

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 4.599 Billion Shares Outstanding48.156 Million Avg 30-day Volume 1.555 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.54
Price to Revenue120.9282 Debt to Equity0.0064 EBITDA-90.547 Million
Price to Book Value5.9633 Operating Margin-564.6894 Enterprise Value1.569 Billion
Current Ratio14.807 EPS Growth0.36 Quick Ratio14.437
1 Yr BETA 0.5589 52-week High/Low 0.0 / Profit Margin-558.8787
Operating Cash Flow Growth-18.3226 Free Cash Flow to Firm (FCFF) TTM -58.158 Million Free Cash Flow to Equity (FCFE) TTM-62.328 Million
Altman Z-Score43.6664
View SEC Filings from FTSV instead.

View recent insider trading info

Funds Holding FTSV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FTSV

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2020-04-07:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-03-02:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-01-10:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-01-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-11-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-08-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-07-18:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-07-11:
    Item 1.01: Entry into a Material Definitive Agreement
  • 8-K: filed on 2019-06-18:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2019-04-30:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    WEISSMAN IRVING

    • Director
    No longer subject to file 2020-04-07 0

    HENNER DENNIS

    • Director
    No longer subject to file 2020-04-07 0

    RHOADS ANN D CHIEF FINANCIAL OFFICER

    • Officer
    No longer subject to file 2020-04-07 0

    BIRD JEFFREY W

    • Director
    No longer subject to file 2020-04-07 0

    BALL KRISTINE M

    • Director
    No longer subject to file 2020-04-07 0

    CLARK IAN T

    • Director
    No longer subject to file 2020-04-07 0

    MCCAMISH MARK ANTHONY PRESIDENT AND CEO

    • Officer
    • Director
    No longer subject to file 2020-04-07 0

    GIBBS CRAIG S CHIEF BUSINESS OFFICER

    • Officer
    No longer subject to file 2020-04-07 0

    TAKIMOTO CHRIS H CHIEF MEDICAL OFFICER

    • Officer
    No longer subject to file 2020-04-07 0

    MAJETI RAVINDRA

    • Director
    No longer subject to file 2020-04-07 0

    LIGHTSPEED VENTURE PARTNERS X, L.P.

    LIGHTSPEED GENERAL PARTNER X, L.P.

    LIGHTSPEED ULTIMATE GENERAL PARTNER X, LTD.

    LIGHTSPEED VENTURE PARTNERS SELECT II, L.P.

    LIGHTSPEED GENERAL PARTNER SELECT II, L.P.

    LIGHTSPEED ULTIMATE GENERAL PARTNER SELECT II, LTD.

    EGGERS BARRY

    LIEW JEREMY

    MHATRE RAVI

    NIEH PETER

    • 10% Owner
    1,497,005 2020-03-11 0

    TAKIMOTO CHRIS H CHIEF MEDICAL OFFICER

    TAKIMOTO CHRIS H CHIEF MEDICAL OFFICER

    • Officer
    0 2019-03-04 0

    WEISSMAN IRVING

    WEISSMAN IRVING

    • Director
    4,265,522 2019-01-09 0

    BLACKSTONE HOLDINGS II L.P.

    BLACKSTONE CLARUS III L.L.C.

    BLACKSTONE HOLDINGS I/II GP INC

    BLACKSTONE GROUP L.P.

    BLACKSTONE GROUP MANAGEMENT L.L.C.

    SCHWARZMAN STEPHEN A

    • 10% Owner
    3,816,951 2019-01-04 0

    MHATRE RAVI

    • 10% Owner
    166,858 2018-08-22 0

    SCHAEPE CHRISTOPHER J

    • Director
    • 10% Owner
    4,392,215 2018-08-16 0

    NIEH PETER

    • 10% Owner
    4,393,173 2018-08-16 0

    SUTTER HILL VENTURES

    • FORMER 10% HOLDER
    No longer subject to file 2018-07-02 0

    LIGHTSPEED VENTURE PARTNERS X, L.P.

    LIGHTSPEED AFFILIATES X, L.P.

    LIGHTSPEED GENERAL PARTNER X, L.P.

    LIGHTSPEED ULTIMATE GENERAL PARTNER X, LTD.

    SCHAEPE CHRISTOPHER J

    EGGERS BARRY

    NIEH PETER

    MHATRE RAVI

    LIEW JEREMY

    • Director
    • 10% Owner
    2,541,404 2018-07-02 0

    LIGHTSPEED VENTURE PARTNERS SELECT II, L.P.

    LIGHTSPEED GENERAL PARTNER SELECT II, L.P.

    LIGHTSPEED ULTIMATE GENERAL PARTNER SELECT II, LTD.

    SCHAEPE CHRISTOPHER J

    EGGERS BARRY

    NIEH PETER

    MHATRE RAVI

    LIEW JEREMY

    • Director
    • 10% Owner
    1,784,269 2018-07-02 0

    COXE TENCH

    • 10% Owner
    3,301,419 2018-07-02 0

    WHITE JAMES N

    • 10% Owner
    3,066,309 2018-07-02 0

    CLARUS LIFESCIENCES III, L.P.

    CLARUS VENTURES III GP, L.P.

    CLARUS VENTURES III, LLC

    HENNER DENNIS

    GALAKATOS NICHOLAS

    LIPTAK ROBERT

    SIMON NICHOLAS

    REQUADT SCOTT

    WHEELER KURT

    • Director
    • 10% Owner
    4,755,440 2018-07-02 0

    SPEISER MICHAEL L

    • 10% Owner
    3,030,299 2018-07-02 0

    DYCKERHOFF STEFAN A

    • FORMER 10% HOLDER
    No longer subject to file 2018-07-02 0

    PULLARA SAMUEL J III

    • FORMER 10% HOLDER
    No longer subject to file 2018-07-02 0

    HADLEY HARBOR MASTER INVESTORS (CAYMAN) II L.P.

    • 10% Owner
    No longer subject to file 2018-07-02 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments